Thrombolytics for PE and right ventricular dysfunction

The Lancet

Volumn 372, Issue 9637, 2008, Pages 447-

  Yusuf, Syed Wamique ^a   Daher, Iyad N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

BRAIN HEMORRHAGE; CLINICAL PRACTICE; ECHOCARDIOGRAPHY; HEART FAILURE; HEART HEMODYNAMICS; HEART RIGHT VENTRICLE FUNCTION; HUMAN; LETTER; LUNG EMBOLISM; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 48649105160     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61193-9     Document Type: Letter

References (5)

1. Kyrle P.A., and Eichinger S. New diagnositic strategies for pulmonary embolism. Lancet 371 (2008) 1315-1316
2. Piazza G., and Goldhaber S.Z. Acute pulmonary embolism. Circulation 114 (2006) e42-e247
3. Tapson V.F. Acute pulmonary embolism. N Engl J Med 358 (2008) 1037-1052
4. Konstatinides S., Geibel A., Heusel G., et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347 (2002) 1143-1150
5. Goldbaher S.Z., Visani L., De Rosa M., and for I. Acute pulmonary embolism: clinical outcome in International Pulmonary Embolism Registry (ICOPER). Lancet 353 (1999) 1386-1389